Tumor-Size-Based Measurements as Endpoint in Cancer Clinical Trials
Publié le
Since the early days of clinical cancer research, given the expected direct cytotoxicity of chemotherapy, tumor shrinkage has been used…
Oncology CRO
Publié le
Oncology CRO Providing Full Range of Biostatistics and eClinical Solutions IDDI is an oncology CRO led by a highly-skilled biostatistical…
Design and conduct of Oncology Clinical Trials
Publié le
Buyse M.: Design and conduct of Oncology Clinical Trials: A Session in Memory of Daniel J. Sargent. Invited lecture at…
Current Status of Surrogates for Survival in Cancer Trials
Publié le
IDDI organized a webinar on the Current Status of Surrogates for Survival in Cancer Trials. VIEW THE RECORDING OF THE…
Personalized Cancer Medicine Needs Randomized Trials
Publié le
IDDI organized a webinar on Personalized Cancer Medicine Needs Randomized Trials. Clinical cancer research is undergoing profound changes, mostly because…
Future of Cancer Clinical Trials
Publié le
IDDI organized a webinar on the Future of Cancer Clinical Trials. Cancer clinical trials have been a major determinant of…
Efficient Designs in Phase I Trials in Oncology
Publié le
IDDI organized a webinar on Efficient Designs in Phase I oncology trials. The key learning objectives of this webinar were…
The Need for Better Endpoints: Towards a More Efficient Drug Development in Oncology
Publié le
IDDI organized a webinar on THE NEED FOR BETTER CLINICAL ENDPOINTS : TOWARDS A MORE EFFICIENT DRUG DEVELOPMENT IN ONCOLOGY The…
Clinical Validity Of Circulating Tumor Cells (CTC)
Publié le
Assessment of Clinical Validity of Circulating Tumor Cells (CTC) Quantification Clinical Validity Of Circulating Tumor Cells (CTC) In Patients With…
Flexible Study Design
Publié le
A Flexible Study Design with Randomization to Placebo The maximum tolerated dose of a new drug, supposed to alleviate some…